ask="N/A"
ask_size="N/A"
average_daily_volume="1011780"
bid="2.01"
bid_size="2200"
book_value="2.06"
change="+0.03"
change_from_200_day_moving_average="0.74"
change_from_50_day_moving_average="0.21"
change_from_52_week_high="-4.66"
change_From_52_week_low="1.47"
change_in_percent="+1.32%"
close="2.31"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-138.84M"
eps_estimate_current_year="-0.71"
eps_estimate_next_quarter="-0.24"
eps_estimate_next_year="-1.39"
ex_dividend_date="N/A"
float_shares="38652000"
high="2.31"
high_52_weeks="6.97"
last_trade_date="2/24/2017"
last_trade_price="2.31"
last_trade_size="30694"
last_trade_time="4:00pm"
low="2.10"
low_52_weeks="0.84"
market_capitalization="114.87M"
moving_average_200_day="1.57"
moving_average_50_day="2.10"
name="Infinity Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="2.00"
open="2.25"
pe_ratio="N/A"
peg_ratio="-0.04"
percent_change_from_200_day_moving_average="+47.13%"
percent_change_from_50_day_moving_average="+10.09%"
percent_change_from_52_week_high="-66.86%"
percent_change_from_52_week_low="+175.00%"
previous_close="2.28"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.11"
price_per_sales="4.08"
revenue="27.80M"
shares_outstanding="49729000"
short_ratio="2.09"
stock_exchange="NMS"
symbol="INFI"
volume="468787"
weeks_range_52="0.84 - 6.97"
